Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low water-soluble uremic toxins.

Raymond Camille Vanholder1, Griet Glorieux, Rita De Smet

  • 1Department of Internal Medicine, University Hospital, Gent, Belgium. raymond.vanholder@rug.ac.be

Advances in Renal Replacement Therapy
|December 19, 2003
PubMed
Summary

Uremic syndrome arises from retained solutes that healthy kidneys normally clear. This review details toxic, low-molecular-weight uremic retention solutes and their harmful effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Lactiplantibacillus plantarum</i> <sup>WJL</sup> ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.

Gut microbes·2026
Same author

Kidney dysfunction regulates gut transporters.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Supplementation with <i>Enterococcus lactis</i> (SF68) and its association with biochemical parameters and inflammatory biomarkers related to renal impairment in dogs with chronic kidney disease.

The veterinary quarterly·2026
Same author

Kidney Function Modulates Gut Microbial Metabolism.

Toxins·2026
Same author

Corrigendum to "Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease." [Biomed. Pharmacother. 197 (2026), 119131].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Area of Science:

  • Nephrology
  • Biochemistry
  • Toxicology

Background:

  • Uremic syndrome results from the accumulation of solutes normally excreted by healthy kidneys.
  • These retained solutes, known as uremic retention products, are categorized by molecular weight, with low-molecular-weight solutes being under 500 D.
  • Understanding these products is crucial for managing kidney disease complications.

Purpose of the Study:

  • To review key water-soluble, nonprotein-bound uremic retention solutes.
  • To detail the primary toxic effects associated with these low-molecular-weight solutes.
  • To provide a comprehensive overview of specific compounds like creatinine, urea, and guanidines.

Main Methods:

  • Literature review of scientific publications.
  • Compilation and synthesis of data on uremic retention solutes.
  • Categorization of solutes based on molecular weight and solubility.

Main Results:

  • Identified and discussed numerous low-molecular-weight uremic retention solutes.
  • Detailed the specific toxicological impacts of each solute reviewed.
  • Highlighted the role of solutes such as creatinine, guanidines, methylamines, and urea in uremic toxicity.

Conclusions:

  • Low-molecular-weight uremic retention solutes contribute significantly to the toxicity observed in uremic syndrome.
  • Further research into the specific mechanisms of toxicity for each solute is warranted.
  • Effective management of uremic syndrome requires addressing the accumulation and effects of these retained solutes.

Related Experiment Videos